본문으로 건너뛰기
← 뒤로

Clinical assessment of Zyplast Implant: a year of experience for soft tissue contour correction.

Journal of the American Academy of Dermatology 1988 Vol.18(4 Pt 1) p. 707-13

Elson ML

📝 환자 설명용 한 줄

【연구 목적】 가교결합 젤라틴(Zyplast Implant)을 이용한 연부 조직 보강술의 임상적 안전성과 효능을 평가하여, 연부 조직 윤곽 불규칙 교정에 대한 환자의 만족도와 부작용 발생률을 규명하는 데 목적이 있다.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • Sensitivity 3%

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Elson ML (1988). Clinical assessment of Zyplast Implant: a year of experience for soft tissue contour correction.. Journal of the American Academy of Dermatology, 18(4 Pt 1), 707-13. https://doi.org/10.1016/s0190-9622(88)70094-8
MLA Elson ML. "Clinical assessment of Zyplast Implant: a year of experience for soft tissue contour correction.." Journal of the American Academy of Dermatology, vol. 18, no. 4 Pt 1, 1988, pp. 707-13.
PMID 3372763

Abstract

The advent of injectable collagen for soft tissue augmentation has opened an entirely new area for the dermatologic cosmetic surgeon and for dermatologists who have a particular interest in the cosmetic aspect of our specialty. Patient demand for correction of soft tissue contour irregularities is high and continues to increase daily. The use of injectable collagen with appropriate technique can provide these patients with significant improvement without great cost or significant side effects. In the year following the introduction of glutaraldehyde cross-linked Zyplast Implant, 188 patients were evaluated for soft tissue augmentation with bovine collagen in my clinical practice. Diagnoses varied from facial elastosis to scars due to acne, pox, trauma, and cancer. Some patients desired changes in facial contour (thicker lips; postrhinoplasty defect). Patient satisfaction was high (83% good or excellent results) and side effects were minimal. In our study we found that 3% of patients demonstrated hypersensitivity to the test implant. Treatment with non-cross-linked Zyderm and Zyplast collagens in the patients with a negative skin test resulted in six hypersensitivity reactions (3%). In these patients reactions were not observed at sites treated only with cross-linked collagen and clinical responses appeared to be directed at the non-cross-linked collagen implant sites. With proper treatment technique and patient consultation, the results obtained with injectable collagen fulfill expectations of treated patients.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 soft tissue scispacy 1
해부 skin scispacy 1
합병증 facial elastosis scispacy 1
약물 glutaraldehyde cross-linked scispacy 1
질환 elastosis C0333448
Elastoid degeneration
scispacy 1
질환 scars C0241158
Scar Tissue
scispacy 1
질환 acne C0001144
Acne Vulgaris
scispacy 1
질환 trauma C0043251
Wounds and Injuries
scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 postrhinoplasty scispacy 1
질환 hypersensitivity C0020517
Hypersensitivity
scispacy 1
기타 Zyplast Implant: a year scispacy 1
기타 collagen scispacy 1
기타 Zyplast scispacy 1
기타 bovine collagen scispacy 1
기타 pox scispacy 1
기타 Zyderm scispacy 1
기타 Zyplast collagens scispacy 1

MeSH Terms

Adolescent; Adult; Aged; Collagen; Evaluation Studies as Topic; Female; Humans; Injections, Intradermal; Male; Middle Aged; Prostheses and Implants; Surgery, Plastic

같은 제1저자의 인용 많은 논문 (4)